PUMA BIOTECHNOLOGY, INC. Quarterly Costs and Expenses in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Puma Biotechnology, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2020 to Q3 2024.
  • Puma Biotechnology, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $58.5M, a 23% increase year-over-year.
  • Puma Biotechnology, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $211M, a 4.92% increase year-over-year.
  • Puma Biotechnology, Inc. annual Costs and Expenses for 2023 was $203M, a 0.64% decline from 2022.
  • Puma Biotechnology, Inc. annual Costs and Expenses for 2022 was $204M, a 18.9% decline from 2021.
  • Puma Biotechnology, Inc. annual Costs and Expenses for 2021 was $252M, a 1.43% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $211M $58.5M +$10.9M +23% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $200M $49.3M -$414K -0.83% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $201M $46.1M -$2.35M -4.84% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $203M $57.4M +$1.72M +3.09% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $201M $47.5M -$7.18M -13.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $208M $49.7M +$2.22M +4.67% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $206M $48.4M +$1.93M +4.15% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $204M $55.7M +$7.03M +14.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $197M $54.7M -$490K -0.89% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $198M $47.5M -$22.6M -32.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $220M $46.5M -$31.5M -40.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $252M $48.6M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $55.2M -$7.69M -12.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $70M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $78M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $62.9M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.